PAUL CORN to Immunosuppressive Agents
This is a "connection" page, showing publications PAUL CORN has written about Immunosuppressive Agents.
Connection Strength
0.036
-
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor). J Immunother Cancer. 2023 03; 11(3).
Score: 0.036